Patient Buzz Series: Facial Acids as Deodorant
179001790017900Facial AcidsSubbing facial cleanser for your deodorant is one of the latest TikTok crazes that’s making headlines in the consumer press. Videos on social media claim that acids such as glycolic acid and salicylic acid are effective in killing the bacteria that causes body odor. However, dermatologists point out that it’s the combination of bacteria and sweat that leads to body odor, so people also should …
Facial Acids
JDD August 2023 Issue Highlights | Special Focus: Psoriasis
178831788317883psoriasisWith a special focus on the topic of psoriasis, check out highlights from the August issue of the Journal of Drugs in Dermatology (JDD) straight from the JDD Editor’s desk: Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis delves into the expert guidance provided by the Psoriasis Expert Group (PEG), encompassing nine crucial statements that offer com …
psoriasis
My Approach to Recognizing, Diagnosing and Treating Psoriasis in Diverse Skin Tones
178741787417874PSORIASISNext Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Amy McMichael, professor and chair of the department of dermatology at Wake Forest University School of Medicine, about her approach to recognizing, diagnosing and treating psoriasis in diverse skin tones. Watch as Dr. McMichael shares why psoriasis workups in patients with skin of color should be different. Don’t pro …
PSORIASIS
Patient Buzz: Melasma Moustache | The Expert Weighs In
178431784317843melasmaGood Housekeeping recently posted an article on how to treat a melasma moustache. What should dermatology clinicians know about treating melasma on the upper lip? What are some up and coming melasma treatments that dermatology clinicians should be aware of? For expert advice, I reached out to Jennifer Rullan, MD, FAAD, a dermatologist in Chula Vista, Ca. How common is melasma on the upper l …
melasma
Baricitinib Therapeutic Cheat Sheet
178311783117831BaricitinibBaricitinib (Olumiant®) is a once daily oral medication recently FDA approved for severe alopecia areata, which is defined as having a Severity of Alopecia Tool (SALT) score of 50 or higher.1 JAK inhibitors are a relatively new class of drug demonstrating efficacy and safety in a range of inflammatory skin disorders. Emerging studies have highlighted baricitinib’s effectiveness for conditions l …
Baricitinib